A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D–culture methods for hepatocellular carcinoma

[1]  Q. Xia,et al.  Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection , 2017, BMC Cancer.

[2]  X. Q. Wang,et al.  XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance , 2017, BMC Cancer.

[3]  Lei Chen,et al.  New knowledge of the mechanisms of sorafenib resistance in liver cancer , 2017, Acta Pharmacologica Sinica.

[4]  Xiaoyun Liu,et al.  Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma , 2017, Oncotarget.

[5]  Ping-Tzu Chen,et al.  Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma , 2017, Oncotarget.

[6]  X. Liang,et al.  Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis , 2017, Oncotarget.

[7]  Hang Zheng,et al.  Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma , 2017, Oncotarget.

[8]  Lequn Li,et al.  Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study , 2017, Oncotarget.

[9]  K. Orihashi,et al.  Correction: In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer , 2016, PloS one.

[10]  Tao Wang,et al.  MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells , 2016, Tumor Biology.

[11]  Hui Sun,et al.  Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. , 2016, Biochimica et biophysica acta.

[12]  Yan Lu,et al.  Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro , 2016, Scientific Reports.

[13]  F. Du,et al.  Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell. , 2016, The international journal of biochemistry & cell biology.

[14]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[15]  C. Howlett,et al.  In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents. , 2016, Hepatobiliary surgery and nutrition.

[16]  J. Geschwind,et al.  Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry , 2015, Liver Cancer.

[17]  F. Gu,et al.  High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer , 2015, Journal of Cancer.

[18]  K. Miyashita,et al.  Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues. , 2015, Oncology letters.

[19]  Hong Wang,et al.  Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma , 2015, Hepatology.

[20]  Zheng Zhang,et al.  The global burden of liver disease: The major impact of China , 2014, Hepatology.

[21]  H. Ueno,et al.  Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial , 2014, BMC Cancer.

[22]  Kristen Jepsen,et al.  Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling , 2013, Cell.

[23]  S. Kumer,et al.  Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation , 2012, BMC Cancer.

[24]  Rong Li,et al.  An engineered three-dimensional gastric tumor culture model for evaluating the antitumor activity of immune cells in vitro , 2012, Oncology letters.

[25]  M. Higashiyama,et al.  Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. , 2010, Lung cancer.

[26]  Y. Yoshioka,et al.  Selective enhancer of tumor vascular permeability for optimization of cancer chemotherapy. , 2004, Biological & pharmaceutical bulletin.

[27]  Y. Takamura,et al.  Prediction of chemotherapeutic response by collagen gel droplet embedded culture‐drug sensitivity test in human breast cancers , 2002, International journal of cancer.

[28]  M. Yasutomi,et al.  An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. , 1997, International journal of oncology.

[29]  M. Cánovas,et al.  Attenuated JNK signaling in multidrug-resistant leukemic cells. Dual role of MAPK in cell survival. , 2017, Cellular signalling.

[30]  Yinying Lu,et al.  MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells. , 2015, Current cancer drug targets.